ArticleClinical and experimental medicine2023

Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab.

Barbora Bacova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.